These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 25064467)

  • 21. Disruption of social cognition in the sub-chronic PCP rat model of schizophrenia: Possible involvement of the endocannabinoid system.
    Seillier A; Giuffrida A
    Eur Neuropsychopharmacol; 2016 Feb; 26(2):298-309. PubMed ID: 26706691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic effect of galantamine with risperidone on impairment of social interaction in phencyclidine-treated mice as a schizophrenic animal model.
    Wang D; Noda Y; Zhou Y; Nitta A; Furukawa H; Nabeshima T
    Neuropharmacology; 2007 Mar; 52(4):1179-87. PubMed ID: 17313962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of atypical and classical antipsychotics on sub-chronic PCP-induced cognitive deficits in a reversal-learning paradigm.
    Abdul-Monim Z; Reynolds GP; Neill JC
    Behav Brain Res; 2006 May; 169(2):263-73. PubMed ID: 16500717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of licking microstructure provides no evidence for a reduction in reward value following acute or sub-chronic phencyclidine administration.
    Lydall ES; Gilmour G; Dwyer DM
    Psychopharmacology (Berl); 2010 Apr; 209(2):153-62. PubMed ID: 20145910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of α7 nicotinic receptors improves phencyclidine-induced deficits in cognitive tasks in rats: implications for therapy of cognitive dysfunction in schizophrenia.
    McLean SL; Grayson B; Idris NF; Lesage AS; Pemberton DJ; Mackie C; Neill JC
    Eur Neuropsychopharmacol; 2011 Apr; 21(4):333-43. PubMed ID: 20630711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance of the nicotinic alpha7 receptor in cognition and antipsychotic-like behavior in the rat.
    Wadenberg MG; Manetti D; Romanelli MN; Arias HR
    Behav Brain Res; 2017 Aug; 333():129-134. PubMed ID: 28684359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topiramate antagonizes MK-801 in an animal model of schizophrenia.
    Deutsch SI; Rosse RB; Billingslea EN; Bellack AS; Mastropaolo J
    Eur J Pharmacol; 2002 Aug; 449(1-2):121-5. PubMed ID: 12163115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repeated low dose of phencyclidine administration impairs spatial learning in mice: blockade by clozapine but not by haloperidol.
    Beraki S; Kuzmin A; Tai F; Ogren SO
    Eur Neuropsychopharmacol; 2008 Jul; 18(7):486-97. PubMed ID: 18242064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat.
    Grayson B; Idris NF; Neill JC
    Behav Brain Res; 2007 Nov; 184(1):31-8. PubMed ID: 17675172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of novel antipsychotics with mixed D(2) antagonist/5-HT(1A) agonist properties on PCP-induced social interaction deficits in the rat.
    Bruins Slot LA; Kleven MS; Newman-Tancredi A
    Neuropharmacology; 2005 Dec; 49(7):996-1006. PubMed ID: 16009387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The dopamine D₃-preferring D₂/D₃ dopamine receptor partial agonist, cariprazine, reverses behavioural changes in a rat neurodevelopmental model for schizophrenia.
    Watson DJG; King MV; Gyertyán I; Kiss B; Adham N; Fone KCF
    Eur Neuropsychopharmacol; 2016 Feb; 26(2):208-224. PubMed ID: 26723167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ErbB signaling antagonist ameliorates behavioral deficit induced by phencyclidine (PCP) in mice, without affecting metabolic syndrome markers.
    Tadmor H; Golani I; Doron R; Kremer I; Shamir A
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Mar; 82():322-331. PubMed ID: 28818421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergistic effect of combined treatment with risperidone and galantamine on phencyclidine-induced impairment of latent visuospatial learning and memory: Role of nAChR activation-dependent increase of dopamine D1 receptor-mediated neurotransmission.
    Wang D; Noda Y; Zhou Y; Nitta A; Furukawa H; Nabeshima T
    Neuropharmacology; 2007 Sep; 53(3):379-89. PubMed ID: 17632185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose-response effect of acute phencyclidine on functional connectivity and dopamine levels, and their association with schizophrenia-like symptom classes in rat.
    Paasonen J; Salo RA; Ihalainen J; Leikas JV; Savolainen K; Lehtonen M; Forsberg MM; Gröhn O
    Neuropharmacology; 2017 Jun; 119():15-25. PubMed ID: 28342897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Behavioral assessment of neuroleptics (3)--Schizophrenia negative symptoms-like model induced by PCP].
    Noda Y; Nabeshima T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Aug; 16(4):123-8. PubMed ID: 8905801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neonatal phencyclidine and social isolation in the rat: effects of clozapine on locomotor activity, social recognition, prepulse inhibition, and executive functions deficits.
    Hamieh AM; Babin D; Sablé E; Hernier AM; Castagné V
    Psychopharmacology (Berl); 2021 Feb; 238(2):517-528. PubMed ID: 33169202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The atypical antipsychotic ziprasidone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat.
    Abdul-Monim Z; Reynolds GP; Neill JC
    J Psychopharmacol; 2003 Mar; 17(1):57-65. PubMed ID: 12680740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The involvement of distraction in memory deficits induced by NMDAR antagonism: relevance to cognitive deficits in schizophrenia.
    Grayson B; Adamson L; Harte M; Leger M; Marsh S; Piercy C; Neill JC
    Behav Brain Res; 2014 Jun; 266():188-92. PubMed ID: 24632009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Normalizing effects of EVP-6124, an α-7 nicotinic partial agonist, on event-related potentials and cognition: a proof of concept, randomized trial in patients with schizophrenia.
    Preskorn SH; Gawryl M; Dgetluck N; Palfreyman M; Bauer LO; Hilt DC
    J Psychiatr Pract; 2014 Jan; 20(1):12-24. PubMed ID: 24419307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult rats.
    Spano MS; Fattore L; Cadeddu F; Fratta W; Fadda P
    Psychopharmacology (Berl); 2013 Feb; 225(3):531-42. PubMed ID: 22903392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.